![]()
- Obama Reiterates Commitment to Boost US-India Ties
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- MGM Pitches Sale to 20 Suitors, Including News Corp
- Holiday Guide to This Season's Smartphones
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wednesday's Economic News Crunch Could Tilt Markets
- NBA D-League On The Rise
- Obama Reiterates Commitment to Boost US-India Ties
- Stifling Anger at Work Can Kill, Survey Finds
- Australia Wheat Exporters Face Challenges: GrainCorp
- The Social Media Gaming Threat
- Japan Export Rebound Eases Fear of New Recession
- China Shipbuilding to Launch $937 Million China IPO
- Rethinking Work
By Stephanie Nebehay GENEVA, Nov 3 (Reuters) - Pregnant women and other people at high risk should be vaccinated against the H1N1 swine flu virus as the cold weather begins to bite in the northern hemisphere, the World Health Organisation (WHO) said on Tuesday. It voiced concern that some vulnerable people are shying away from the pandemic vaccine, which the WHO stressed had not caused any unusual side effects in hundreds of thousands of people to have received it worldwide so far. "Certainly the fact that the vaccine isn't being used by those who would have access to it and who would be in priority risk groups is of concern, yes," WHO spokesman Gregory Hartl told a news briefing. At least 5,712 people have died from the swine flu virus, according to the United Nations agency. Health workers, pregnant women and people with conditions such as asthma are deemed at greatest risk and should be top priority for getting the shot. "We have seen many, many instances of people in high risk groups such as pregnant women who have very severe disease or outcomes. These outcomes could be in all likelihood avoided if one were to get vaccinated," Hartl said. Unlike seasonal flu, which is most dangerous to the elderly, H1N1 is hitting younger adults and children especially hard. The WHO recommends a single vaccine dose for protecting adults against H1N1. It has also urged governments to consider giving a single dose to as many children under age 10 as possible, but says more research is needed into child dosages. In the United States, studies show that children under the age of 9 will need two doses of the vaccine to be fully protected, officials there said on Monday. Parts of North America and Europe have already crossed the epidemic threshold, ahead of the normal influenza season which peaks in January-February for the northern hemisphere, WHO says. "There is substantial influenza activity and we would expect to see more.
Certainly the indications are that this will become something quite widespread across the northern hemisphere temperate zones as we go forward through the late autumn and winter," Hartl said. But the WHO is reluctant to speak of a "second wave" of outbreaks, as the virus may have just been less active in the summer months, he said. Colder weather favours its spread. Countries from China to the United States have rolled out vaccination campaigns and the rare side effects have been mild, in line with those caused by seasonal flu vaccines, Hartl said. GlaxoSmithKline and Sanofi-Aventis are among some 25 drugmakers companies producing pandemic vaccine. (Editing by Jonathan Lynn and Myra MacDonald) Keywords: FLU/WHO (geneva.newsroom@thomsonreuters.com; Tel: +41 22 733 3831) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
- Remember when auto shows were major events where new models could generate buzz?
- CNBC’s Mike Huckman visits a cutting-edge plant to see how the flu vaccine of the future is being made.
- People who bottle up their anger at work are up to five times more likely to suffer a heart attack, a study found.
- Playboy will outsource its publishing operations in a bid to become profitable again.
- A new McDonald's in Manhattan is the nation's first to sport a sleek, chic interior imported from stores in London and Paris.
- For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.











